Navigation Links
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Date:2/3/2009

y. The primary efficacy endpoint of the study was the increase in mean daily "ON" time ("ON" time without dyskinesia plus "ON" time with minor dyskinesia) during an 18-hour period as assessed by patients' recordings on diary cards.

Out of the 669 randomized patients, 89% of patients treated with safinamide completed the study (91% in the 50 mg dose group and 87% in the 100 mg dose group) compared to 89% in the placebo group. Over 90% of patients who completed the initial 24 weeks of treatment elected to enter a 78-week, placebo-controlled double-blind extension study, which is ongoing, to specifically assess the effect on dyskinesias as primary endpoint.

Secondary efficacy endpoints of this study were also met, including decrease in daily "OFF" time, decrease in mean "OFF" time following first morning dose of levodopa, mean change from baseline in the Unified Parkinson's Disease Rating Scale (UPDRS)(2) Section III (motor) score during "ON" time and mean change in Clinical Global Impression of severity of disease and change from baseline (CGI)(3). The incidence of dropouts, serious adverse events or clinically notable events among the three groups of the study were comparable.

Full study results after completion of ongoing analyses will be submitted for presentation at upcoming scientific meetings.

Merck Serono has exclusive worldwide rights to develop, manufacture and commercialize safinamide in Parkinson's disease, Alzheimer's disease and other therapeutic applications, as per the agreement signed with Newron in 2006.

About safinamide

Safinamide, an alpha-aminoamide derivative that is orally formulated, is currently being developed by Merck Serono and Newron as an add-on treatment for patients with Parkinson's disease. Safinamide is believed to have a novel dual mechanism of action based on the enhancement of the dopaminergic function (through reversible inhib
'/>"/>

SOURCE Merck Serono
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
2. Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
3. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
4. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
5. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
6. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
7. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
8. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
9. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
10. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
11. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 SynCardia Systems, Inc., manufacturer of the ... Inc. 5000 named by the business magazine Inc. ... Health Canada and CE approved Total Artificial Heart, which ... heart transplant," says Michael P. Garippa , SynCardia,s ... care for patients dying from end-stage biventricular heart failure." ...
(Date:8/26/2014)... LONDON , August 26, 2014 ... ( http://www.fdna.com ) and London Medical Databases Ltd. ( ... offer, for the first time, online access to the ... FDNA, developer of the Facial Dysmorphology Novel Analysis ... Face2Gene [ TM ] , the only ...
(Date:8/26/2014)... , Aug. 26, 2014 Novira Therapeutics, ... for curative treatment of chronic hepatitis B virus (HBV) ... M.D., F.A.C.P., was appointed the Chair of its Scientific ... function as a Senior Advisor to the Company.  ... our SAB as Chair," said Christian Schade , ...
Breaking Medicine Technology:Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... Neuralstem, Inc. (NYSE Amex: CUR ) announced ... Phase I safety trial of Neuralstem,s human spinal cord ... Lou Gehrig,s disease), and unpaid Neuralstem consultant, presented interim ... reported yesterday at the American Academy of Neurology (AAN ...
... April 12, 2011 Lanx®, Inc., a privately held ... devices for spinal surgery, today announced the initial launch ... clearance in February. The announcement was made at the ... Denver, CO. The Durango system is ...
Cached Medicine Technology:Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial 2Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial 3Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial 4Lanx®, Inc. Launches Durango™ Stand-Alone ALIF System 2
(Date:8/27/2014)... 27, 2014 A recently published ... importance of time in correcting coagulopathy to prevent permanent ... variety of anticoagulants and examines medical conditions alleged to ... research, although anticoagulants have been approved by the FDA ... they are also known to affect the consistency of ...
(Date:8/27/2014)... Hospitals and health systems can have ... one they add brings the challenge of additional integration ... manage. Kaweah Delta Health Care District is moving in ... vendors who offer full-featured solutions that are easy to ... Delta selected Access to provide electronic forms and ...
(Date:8/27/2014)... In My Solitude, a leader in luxe self-care products, ... number of women from college students and busy moms to ... at the same time. , The Journey Candle Collection, a ... to help women stay focused on a specific task, moment ... candle and enjoy the fragrance. , “When setting a ...
(Date:8/27/2014)... TX (PRWEB) August 27, 2014 PCOS ... women and puts them at risk for a number ... not widely known or well understood even within the ... as excess body hair (hirsutism) and excess body fat ... not aware that their problems are caused by PCOS. ...
(Date:8/27/2014)... Janice Holly Booth didn’t choose to travel ... her on an adventure outing to southern Utah where she’d ... harnesses and rappelling into mysterious, dark and potentially dangerous canyons. ... not my last,” she says. “I travelled alone for more ... edge, and experienced first-hand the kind of fear that keeps ...
Breaking Medicine News(10 mins):Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:Kaweah Delta Health Care District Selects Access to Provide Paperless E-Forms and Electronic Patient Signatures 2Health News:Kaweah Delta Health Care District Selects Access to Provide Paperless E-Forms and Electronic Patient Signatures 3Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2
... Physical activity is an important health behaviour for ... has been understudied and underappreciated. This book, edited ... explores in depth the relation between physical activity ... treatments, recovery after treatments, long-term survivorship, secondary prevention, ...
... shown for the first time that damage to a particular ... are associated with multiple sclerosis. The study is available ... processes in MS are not well understood, but an important ... cells involved in immune defense through the blood-brain barrier. ...
... use to compensate for the turbulence of the atmosphere ... an artificial star called a guide star and use ... Lihong Wang, PhD, the Gene K. Beare Distinguished ... Louis, has invented a guide star for biomedical rather ...
... Kathleen Doheny HealthDay Reporter , THURSDAY, Feb. ... better than aspirin for stroke prevention in some patients ... as atrial fibrillation, according to research presented Thursday. ... use by the U.S. Food and Drug Administration. But ...
... SAN FRANCISCO (February 11, 2011) In a study to ... annual meeting, The Pregnancy Meeting , in San Francisco, researchers ... risk for preterm birth participated in a preterm birth prevention ... fewer cases of infant morbidity. The National Center for ...
... Reporter , THURSDAY, Feb. 10 (HealthDay News) -- While ... also hold true: More than one-quarter of married Americans ... has strengthened their union. University of Virginia researchers ... for 29 percent of the people surveyed. Among those ...
Cached Medicine News:Health News:Researchers find reduced levels of an important neurotransmitter in MS 2Health News:A guide star lets scientists see deep into human tissue 2Health News:A guide star lets scientists see deep into human tissue 3Health News:A guide star lets scientists see deep into human tissue 4Health News:A guide star lets scientists see deep into human tissue 5Health News:A guide star lets scientists see deep into human tissue 6Health News:New Drug May Help Patients With Irregular Heartbeat Avoid Stroke 2Health News:New Drug May Help Patients With Irregular Heartbeat Avoid Stroke 3Health News:Study finds preterm birth clinic attendence leads to major reduction in infant disability 2Health News:Recession Strengthens Some Marriages: Survey 2Health News:Recession Strengthens Some Marriages: Survey 3
30 cm - 11 3/4, packages 5 pcs....
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Medicine Products: